Introduction
Surface-attached biofilm forms of bacteria are responsible for approximately 80% of all infections [1] . Biofilm bacteria are a sessile community characterised by cells that are embedded within an extracellular polymeric matrix and exhibit an altered phenotype with respect to growth rate and gene transcription compared to planktonic bacteria. Biofilms demonstrate increased resistance characteristics and are associated with treatment failure in chronic wounds and implant associated infections where standard in vitro susceptibility assays (e.g. minimum inhibitory and bactericidal concentrations) do not correlate to clinically effective concentrations [2] . They are responsible for high rates of morbidity and mortality within infectious diseases such as cystic fibrosis, dental, wound and medical device infections. A major difficulty encountered clinically is that biofilm forms commonly require 10 to 1000 times the concentration of antibiotic to achieve bactericidal action compared to more susceptible free-floating, liquid planktonic forms. Biofilms lead to a profile of increased tolerance to antibiotic therapy; survival of a bacterial population exposed to a subtherapeutic concentration of antibiotic and increased spread of antimicrobial resistant strains [3] . The gel-like extracellular polysaccharide biofilm matrix presents a physical barrier to: phagocytosis and the host's immune response; opsonization; the diffusion of antibacterials and physical/shear stress. Biofilms are primarily anionic in charge and have the ability to bind to and prevent the permeation of several cationic antibiotics including aminoglycosides [4] . Bacterial cells situated within the lower depths of the biofilm are therefore relatively protected from environmental and therapeutic stress. This enclosed environment allows the community of bacteria to share genes, including those that code for multidrug resistance, via plasmid exchange [5] . Resistance to antimicrobials is one of the most pressing issues impacting society resulting in at least 700,000 deaths worldwide per year [6] . The Centers for Disease Control and Prevention estimates that drug-resistant bacteria cause two million illnesses and approximately 23,000 deaths each year in the US alone. Recognising the severe threat to society, the US government released a $1.2 billion five-year national action plan in 2015 aimed at combating antibiotic-resistant bacteria [7] . Therefore efforts have focused on alleviating the burden of biofilm-based infections using a variety of innovative approaches including the use of antimicrobial peptides [8] , non-thermal plasma [9] and antibiotic-decorated nanoparticles [10] . During our study of peptide-based nanomaterials [11] , we discovered that diphenylalanine (FF) peptide nanotubes were able to selectively eradicate mature 24 hour biofilms of bacteria implicated in a variety of infections. FF represents the minimal peptide motif for self-assembling nanostructures and also more significantly to this work, antibiofilm activity. Their mode of action is via disruption of the exopolymer biofilm matrix and targeting of bacterial cell membranes. They were particularly effective against biofilm forms of Gram-positive staphylococci widely implicated in endocarditis, intravascular catheter, wound and bone infections [12] .
Peptide nanotubes have been studied as next generation materials for a variety of chemical, technological, engineering and drug delivery applications [13] . Similar to carbon nanotubes, they possess an advantageous high aspect ratio (length-to-diameter) which is important to mediate cellular interactions including cell internalization as observed by Gratton and colleagues [14] . The Mitragotri group has previously demonstrated that tubular nanoparticle structures provide improved transport and delivery of drugs throughout the body, adhering better to cells than spherical particles due to a larger surface area in contact with target cells [15] . This group also demonstrated that nanotubes possess an enhanced surface area allowing greater encapsulation efficacy of drug relative to alternative platforms, such as nanospheres, nanocubes and liposomes, meaning more drug reaches its intended site of action at a lower therapeutic dose combined with a reduced likelihood of drug induced systemic side effects [16] . Compared to carbon and metallic nanotubes, peptide variants possess the additional benefits of improved chemical versatility due to the range of amino acid functional groups, enhanced biocompatibility, tunable biodegradability and variable immunogenicity [17] . Interest in dipeptide nanotubes, for example the FF motif, is particularly high as the reduced amino acid chain length makes their synthesis and manufacturing upscale more cost-effective and amenable to widespread industrial applications [18] . Figure   1 (a-c) outlines the structure of the FF motifs studied, with (a) representing FF with a carboxylic acid terminus (NH2-FF-COOH), (b) corresponding the d-enantiomeric isomer of (a) (NH2-ff-COOH), and (c) FF possessing two amino terminals (NH2-FF-NH2). Each is synthesized using Fmoc-based protocols. FF motifs have the ability to spontaneously selfassemble into nanotubes in solution due to intermolecular - interactions between neighboring phenyl groups, hydrophobic interactions and hydrogen bonding with surrounding solvent, leading to primarily β-sheet secondary structures as previously demonstrated ( Figure 1d ) [19] . 
Methods

1 H NMR analysis
Peptide identities were confirmed using 1 H NMR analysis in deuterated DMSO (d6-DMSO).
NMR experiments were carried out on a Bruker Ultrashield Plus 400 MHz (Bruker, Coventry, UK). Peptides were identified using a 64-scan proton NMR analysis. To prepare samples 15 mg of peptide was dissolved in ~ 550 microliters of deuterated DMSO immediately before testing. Spectra were processed and identities confirmed using ACD labs academic NMR processor (Figures S1-S3).
Peptide nanotube formulation
The stepwise formulation of nanotubes is outlined in Table 1 . NH2-FF-COOH, NH2-ff-COOH or NH2-FF-NH2 was dissolved in sterile UltraPure™ DNase/RNase-free distilled water at room temperature. To allow peptides to quickly reach their monomeric fully dissolved state, the peptide suspensions are heated to 65 °C for 30 minutes and then allowed to selfassemble at room temperature over a period of 24 hours [20, 21] . To achieve the working peptide nanotube concentration range, a stock solution is formed at 10 mg/ml. This stock solution is vortexed and examined visually to confirm complete dissolution of the peptide powder. This is followed by immediate serial dilution to test concentrations with UltraPure™ DNase/RNase-free distilled water before assembly occurs at room temperature over 24 hours. The pH of peptide nanotube suspensions was titrated to pH 7 ± 0.2 with approximately 20 µL of 1 M NaOH solution to ensure pH was constant. 
Hemolysis assay
Peptide nanotubes were assayed spectrophotometrically for their ability to induce hemoglobin release from fresh equine erythrocytes according to the method previously utilized by our group [22] . Fresh defibrinated equine erythrocytes were washed three times with equal volumes of PBS. After centrifugation for 15 minutes at 900 g, erythrocytes were resuspended 4% v/v in PBS. Equal volumes (100 µL) of the erythrocyte suspension were added to each well of a 96-well microtiter plate. Erythrocytes were subsequently exposed to (100 % NPN uptake reference) as previously described [26] . 100 μL of HEPES buffer ( hours at room temperature, the samples were mounted on aluminium stubs using fast drying epoxy resin and gold spluttered in pure gold before SEM imaging.
Statistical methods
Statistical analyses were performed using Microsoft Excel 2013 and GraphPad Prism 6.
Standard deviations were obtained at each concentration of peptide nanotube tested based on three replicates for quantitative bacterial viability assays and mean values obtained.
Statistical analyses were employed using a one way Analysis of Variance (ANOVA) with a Tukey's multiple comparisons test used to identify individual differences between the reduction in bacterial viability (planktonic and biofilm) for each peptide nanotube relative to the negative bacterial growth control. MTS and hemolysis data was compared by the same statistical method, with percentage cell viability and hemolysis compared to the media only (100% cell viability) and PBS non-hemolytic negative controls. One way ANOVA were employed as data was shown to be normally distributed using the Kolmogorov and Smirnov method. In all cases a probability of p< 0.05 denoted significance.
3. Results and discussion.
Peptide nanotube formulation and morphology
The majority of previous research has focused on using highly toxic organic solvents, such as hexafluoro-2-propanol (HFIP) and methanol, to formulate and permit complete dissolution of FF molecules. In these examples FF nanotube formation proceeds via subsequent dilution in water [28] . Our group was able to form defined nanotube structures (163.731.8 nm in diameter, Figure 2 ) for all three peptides at concentrations of 1 mg/mL and above using Ultrapure™ water as a formulation medium and heating to 65 °C, then cooling to room temperature (Table 1 ) [20] . This is a significant advantage in the preparation of FF nanotubes, in order to reduce potential for solvent induced toxicity. This is a key consideration for the future translation of this technology in a drug delivery and healthcare setting. 
Cell cytotoxicity and viability
Cell viability (LIVE/DEAD® staining, MTS) assays confirm that both NH2-FF-COOH and its d-enantiomeric equivalent NH2-ff-COOH exhibit minimal toxicity (Figures 3, 4 , S4) to subcutaneous fibroblast cells (NCTC clone 929, ATCC® CCL-1) at concentrations studied (≤10 mg/mL). These include concentrations that completely eradicate staphylococcal biofilms (NH2-FF-COOH and NH2-ff-COOH: 10 mg/mL). Interestingly the increased cationicity provided by an extra terminal amine within NH2-FF-NH2 is sufficient to result in toxicity at concentrations greater than or equal to 2.5 mg/mL as observed by LIVE/DEAD® ( Figure 3 ) and MTS ( Figure 4A ) assays. FF nanotubes also demonstrate minimal toxicity against mammalian membranes using a hemolysis assay ( Figure 4B ). Each peptide demonstrated no significant hemolysis when compared to the negative PBS control. Figure  3A also demonstrates FF nanotubes are able to retain their nanotube architecture within tissue culture media, at conditions (pH, temperature, ionic strength) that mimic the physiological environment. However further long-term stability studies are required to elucidate their wider potential as pharmaceuticals [29] . 
Planktonic and biofilm bacterial susceptibility
Bacterial susceptibility assays were performed initially against planktonic forms of microorganisms widely implicated in bacterial infectious disease. These were, Gram-positive S. aureus NCTC 10788 and S. epidermidis ATCC 12228, and Gram-negative E. coli ATCC 15597 and P. aeruginosa PA01 ( Figure 5C -F). From these preliminary studies it was evident that NH2-FF-COOH was the most potent antibacterial nanotube demonstrating greater than 3 Log10 reduction in colony forming units per milliliter (CFU/mL), equivalent to higher than 99.9% decrease, at 5 mg/mL and complete bactericidal kill at 10 mg/mL against planktonic Gram-positive S. aureus and S. epidermidis (Figures 5C and 5D ). NH2-FF-COOH was less active against Gram-negative bacteria ( Figures 5E and 5F ) failing to achieve bactericidal activity at 10 mg/mL but still demonstrating 3 Log10 reduction (99.9%), a clinical milestone for inhibitory action, at this concentration [30] . Reduced efficacy in Gram-negative bacteria is likely due to differences in the membrane architecture. Gram-negative bacteria possess an extra outer lipopolysaccharide membrane that limits influx and uptake of antibiotic molecules [31] . This outer membrane has proven to be a major obstacle in antibiotic uptake, treatment efficacy and drug development within Gram-negative infections [32] . The ability of the most promising peptide nanotube, NH2-FF-COOH, to permeate the outer lipopolysaccharide membrane was studied using NPN as a fluorescent probe to indicate whether the Gramnegative membrane is compromised in E.coli and P. aeruginosa [26] . In the presence of 10 mg/mL NH2-FF-COOH and NH2-ff-COOH, Gram-negative bacteria show increased NPN uptake, demonstrating similar efficacy (~100%) of NPN uptake relative to polymyxin B positive control ( Figure S5, S6) . Such uptake is sufficient to allow significant bactericidal activity in planktonic forms of E. coli and P. aeruginosa but not within Gram-negative biofilms.
The ability of FF nanotubes to kill mature surface-attached bacterial biofilm forms is more relevant to clinical infections and we studied this phenomenon using a MBEC assay™.
Biofilms of each bacteria were grown on polystyrene pegs for 24 hours. Despite biofilm forms being associated with increased tolerance to antibiotics, requiring 10 to 1000 times antibacterial concentrations to achieve equivalent planktonic efficacy [3] , NH2-FF-COOH was able to obtain greater than 3 Log10 CFU/mL reduction at 5 mg/mL and a MBEC value (total biofilm kill) of 10 mg/mL against S. aureus biofilms after 24 hours ( Figure 5A ). This is equivalent to its efficacy against planktonic forms of staphylococci ( Figure 7C and D) .
At concentrations of 5 mg/mL the L-enantiomeric FF variant (NH2-FF-COOH) demonstrated
improved antibiofilm activity against S. aureus biofilm relative to the D-variant ( Figure 5A ).
The increased biofilm potency of our NH2-FF-COOH was also observed for planktonic forms of S. aureus ( Figure 5C) and Gram-negative pathogens tested ( Figure 5E and 5F ). This is an interesting result that opposes what has been observed in several recent studies relating to L, D structural confirmation and biofilm activity. Previous reports have demonstrated that Dforms of amino acids, including phenylalanine, act as biofilm dispersal agents and enhance the activity of standardly employed colistin and ciprofloxacin against P. aeruginosa biofilms and rifampicin against S. aureus [33] . Manabe and colleagues compared the antimicrobial properties of D-and L-forms of KLKLLLLLKLK-NH2, a sequence derived from the antimicrobial peptide sapesin B [34] . They discovered that the D-enantiomer demonstrated higher affinity for bacterial cell wall components, such as peptidoglycan in S. aureus, and that this served as a potential means to improve transfer of peptide to the bacterial plasma membrane, resulting in improved antibacterial potency. There are more widespread reports in the literature that biological enhanced activity is due to increased resistance of D-isomers to bacterial proteases released in vitro rather than specific stoichiometric targeting [35] .
Whilst such studies are suggesting a link between enantiomeric confirmation and antibiofilm activity in peptides the overall picture is inconclusive with the vast majority of studies demonstrating no significant differences in D, L configuration and antibiofilm activity.
Therefore further investigations of such a link are warranted within our low molecular weight motifs. The study of the differences in short-range molecular interactions between L, Denantiomers and bacterial cell surface components is in its infancy, especially for ultrashort peptides, and requires further characterisation before this can be conclusively reported. Due to its amphipathic nature, NH2-FF-COOH's mechanism of action was hypothesized to be via formation of ion channels in bacterial membranes and/or a surfactant-like disintegration of the biofilm exo-polysaccharide architecture and bacterial cell membranes as previously observed for a variety of naturally occurring antimicrobial peptide motifs and peptide nanotube structures [21, [36] [37] [38] , This was later confirmed and shown to be concentration dependent via SEM analysis ( Figure 6B, Figure S7 ). NH2-FF-COOH was able to selectively disrupt the peptidoglycan cell wall and cytoplasmic lipid membrane of Grampositive S. aureus resulting in cell lysis and death. Targeting of bacterial membranes is a preferred mode of action compared to blocking single biomolecular pathways as it is more difficult for bacteria to develop resistance via minor modification of an important enzyme or signaling pathway. Although incidences of resistance have been reported due to alteration of specific membrane bound receptors in Gram-negative species [39] , the entire structure of the bacterial membrane would have to be modified in order to completely negate surfactantlike activity [37] . However, no significant reduction was observed for Gram-negative biofilms at concentrations employed ( Figures 5B) . No pore-like structures were observed in the outer envelope of Gram-negative E.coli ( Figure 6D ) suggesting membrane damage did not occur.
The reduction in activity of NH2-FF-COOH against Gram-negative biofilms compared to planktonic forms is due to difficulty permeating the biofilm matrix, which is primarily composed of polyanionic alginate (P. aeruginosa) or colanic acid (E. coli) that acts as a sponge to block diffusion of amphipathic and cationic peptides [40] . This ability may be especially relevant to negating the antibacterial activity of cationic NH2-FF-NH2.
Whilst conclusive evidence for antimicrobial peptide selectivity for bacterial over mammalian cells is still forthcoming, there is an acceptance amongst researchers that physiochemical properties, especially amphiphilicity, are of significant importance given that the vast majority of antimicrobial peptides contain hydrophobic and charged regions [37, 41] . Such characteristics are important for peptides which are membrane active, either enabling cell entry for intracellular targeting or membrane disruption. Regardless, the difference in bacterial (cell wall and membrane) and mammalian membrane architecture plays a key role in antimicrobial peptide cell selectivity given that this is the first structure the peptide will encounter upon exposure to cells. A large proportion of bacterial cell membranes are composed of acidic phospholipids, such as cardiolipin and phosphatidylglycerol, leading to an overall net negative charge [42] . Bacterial cell walls also contain large amounts of anionic components including teichoic acids and lipoteichoic which form part of the peptidoglycan of Gram-positive bacteria. Lipopolysaccharides present in the outer membrane of Gramnegative bacteria are also anionic [43] . Mammalian cell membranes however possess a net neutral charge due to the presence of zwitterionic phosphatidylcholine and sphingomyelin in the outer membrane surface [44] . Cholesterol, which itself is neutrally charged, plays an important role in membrane stabilization against antimicrobial peptide attack and has been shown to increase the stiffness and cohesiveness of the lipid bilayer membrane [45] . Most anionic phospholipids tend to be unexposed, enclosed within the inner surface of the plasma membrane [43] .
Taking into account the above factors that are deemed to govern antimicrobial peptide activity, it would be expected that increasing the cationic charge of FF via substitution of a carboxylic acid with an amide would be favourable to improved selectively for bacterial cell membranes. However, the exact mechanism by which amphipathic antimicrobial peptides mediate membrane disruption remain unclear as the exact conformation such peptides in bacterial and mammalian membranes is unknown. The hydrophobic: charge balance is extremely important for large molecular weight, naturally occurring antimicrobial peptides but it is especially significant in ultrashort peptide systems (≤7 amino acids) whereby change in one amino acid unit or functional group can result in hydrophobic: charge imbalance, compromising activity or leading to increased mammalian cell cytotoxicity [37, 46] .
Substantial increase or decrease in amphipathicity, charge, hydrophobic characteristics have been observed to cause similar effects [44] .
For the FF motif, it is possible that substitution of the carboxylic acid functional group in NH2-FF-COOH and NH2-ff-COOH with an amide moiety (NH2-FF-NH2) is sufficient to increase cationicity, resulting in a shift in the hydrophobic: charge balance, leading to significant mammalian cell toxicity and lowered antimicrobial potency within this low molecular weight dipeptide system. This is demonstrated by a change in the predicted physiochemical properties for NH2-FF-NH2 at a formulated pH of 7, where it possesses an apparent overall charge of +0.836 and LogD of 0.606 (LogP: 1.39) (Table S1 ). Unsurprisingly both L and D carboxylic acid terminated FF variants (NH2-FF-COOH and NH2-ff-COOH) share similar physiochemical characteristics, possessing a predicted LogD of -0.099 and a relatively neutral charge (-0.08). However, it must be emphasised these are only predicted values for physiochemical properties, serving as a useful tool for approximating the hydrophobic: charge balance and antimicrobial effects. Recent research in self-assembling peptide hydrogelator systems have demonstrated a link between self-assembly and changes in physiochemical properties, such as pKa [47] . Whilst this has not been explicitly linked to selfassembling nanotube systems, there may be a similar effect, adding a further layer of complexity to predicting antimicrobial activity for self-assembling peptides. Nonetheless it serves as an interesting area for further study.
The presence of self-assembly has also been specifically linked to providing antimicrobial activity in peptide-based systems [48] . FF forms the fundamental self-assembly motif of βamyloid, the main component of plaques linked to Alzheimer's and type-2 diabetes [49] . β-amyloid also demonstrates antimicrobial activity and the ability to form transmembranous pores in bacterial and mammalian cells, suggesting a connection between assembly, folding, structural conformation and its mode of antimicrobial action [50, 51] . To our knowledge, the FF peptide motif does not have any specific enzymatic targets, therefore antibacterial activity may due to surfactant-like action on bacterial membranes and biofilms and/or the formation of ion channels by FF nanotubes resulting in membrane depolarisation as observed for βamyloid peptides [52] . Self-assembling FF systems has also been recently associated with bacterial membrane depolarization, inducing the upregulation of stress response regulons, resulting in severe bacterial cell damage [21] . However, more studies must be performed to explicitly link self-assembly of aromatic short peptide derivatives to antibacterial and antibiofilm activity, especially in relation to membrane interactions, structural assembly, presentation of functional groups and molecular modelling. This will enable tailoring of the FF peptide structure to improve antimicrobial selectivity and spectrum of activity. 
Conclusions
In conclusion, we demonstrate NH2-FF-COOH to be a promising peptide nanomaterial to target Gram-positive biofilm infection and of potential use as a future therapy in the treatment of medical device, bone and wound infections attributed with high rates of treatment failure and antibiotic resistance due to the presence of staphylococcal biofilms.
Despite being neutrally charged NH2-FF-COOH and NH2-ff-COOH nanotubes are able to selectively target bacterial cell membranes and permeate the biofilm matrix via a surfactantlike mechanism, resulting in total biofilm eradication at 10 mg/mL. This may also due to their ability of self-assembled FF sequences to form ion channels in bacterial cell membranes mimicking those observed recently for β-amyloid. Both NH2-FF-COOH and NH2-ff-COOH nanotubes have minimal toxic effects on mammalian cells highlighting further their potential to be clinically translated. Further studies will focus on formulation and stability of NH2-FF-COOH for delivery to medical device, bone and wound sites. Despite the relative lack of activity against biofilms of E. coli, NH2-FF-COOH and NH2-ff-COOH nanotubes did demonstrate an ability to penetrate the outer membrane of Gram-negative bacteria as observed via a NPN assay. Whilst this did not result in bacterial cell death in biofilm forms, it is an important observation. Molecules with the ability to cross or disrupt the outer membrane of Gram-negative biofilm bacteria have the potential to be utilized synergistically to repurpose licensed antibiotics that target the peptidoglycan inner layer and tend to be Gram-positive selective, for example the glycopeptide vancomycin or the macrolide erythromycin. They may also lower the effective therapeutic dose of antibiotics currently licensed to treat Gram-negative biofilms, reducing side effects to the patient and development of antimicrobial resistance. The architecture of these peptide nanostructures mean antibiotics could be potentially encapsulated within the hollow hydrophilic pores of FF nanotubes or within their hydrophobic phenylalanine walls. Nanotubes have previously been explored for drug delivery purposes and because of NH2-FF-COOH and NH2-ff-COOH's selectivity for bacterial cells they are worthy of further exploration as an antibiofilm drug delivery platform. 
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